Contact this trialFirst, we need to learn more about you.
Tirzepatide for Pediatric Type 2 Diabetes
Recruiting1 awardPhase 3
Philadelphia, Pennsylvania
This trial is testing the safety and effectiveness of tirzepatide compared to placebo in children and adolescents with type 2 diabetes who are also taking metformin, basal insulin, or both. The study will last 60 weeks with 14 clinic visits and 6 phone visits.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.